Assessing the performance of the Cell Painting assay across different imaging systems
Cytometry Part A · 2023-11 · 103 (11) · 915-926
DOI: 10.1002/cyto.a.24786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytometry Part A, online erschienen am 03.10.2023. Verfasst von Callum Tromans-Coia und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department: Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Hauptthemen laut MEDLINE: Microscopy, Biological Assay. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Chan Zuckerberg Initiative, National Institutes of Health.
Abstract (Originalsprache)
Quantitative microscopy is a powerful method for performing phenotypic screens from which image‐based profiling can extract a wealth of information, termed profiles. These profiles can be used to elucidate the changes in cellular phenotypes across cell populations from different patient samples or following genetic or chemical perturbations. One such image‐based profiling method is the Cell Painting assay, which provides morphological insight through the imaging of eight cellular compartments. Here, we examine the performance of the Cell Painting assay across multiple high‐throughput microscope systems and find that all are compatible with this assay. Furthermore, we determine independently for each microscope system the best performing settings, providing those who wish to adopt this assay an ideal starting point for their own assays. We also explore the impact of microscopy setting changes in the Cell Painting assay and find that few dramatically reduce the quality of a Cell Painting profile, regardless of the microscope used.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department: Imaging Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Nikon Instruments Inc., Melville, New York, USA.
- Yokogawa Electric Corporation, Kanazawa, Ishikawa, Japan.
- Yokogawa Corporation of America, Newnan, Georgia, USA.
- Revvity, Inc., Waltham, Massachusetts, USA.
- Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
ORCID-Profile: Callum Tromans-Coia, Anne E Carpenter, Beth A Cimini
Förderung
- NIGMS NIH HHS
- Chan Zuckerberg Initiative
- National Institutes of Health
Zitieren
APA
Tromans-Coia, C., Jamali, N., Abbasi, H. S., Giuliano, K. A., Hagimoto, M., Jan, K., Kaneko, E., Letzsch, S., Schreiner, A., Sexton, J. Z., Suzuki, M., Trask, O. J., Yamaguchi, M., Yanagawa, F., Yang, M., Carpenter, A. E., & Cimini, B. A. (2023). Assessing the performance of the Cell Painting assay across different imaging systems. Cytometry Part A, 103(11), 915-926. https://doi.org/10.1002/cyto.a.24786
Vancouver
Tromans-Coia C, Jamali N, Abbasi HS, Giuliano KA, Hagimoto M, Jan K, et al. Assessing the performance of the Cell Painting assay across different imaging systems. Cytometry Part A. 2023;103(11):915-926. doi:10.1002/cyto.a.24786
BibTeX
@article{TromansCoia2023,
author = {Tromans-Coia, Callum and Jamali, Nasim and Abbasi, Hamdah Shafqat and Giuliano, Kenneth A and Hagimoto, Mai and Jan, Kevin and Kaneko, Erika and Letzsch, Stefan and Schreiner, Alexander and Sexton, Jonathan Z and Suzuki, Mahomi and Trask, O Joseph and Yamaguchi, Mitsunari and Yanagawa, Fumiki and Yang, Michael and Carpenter, Anne E and Cimini, Beth A},
title = {Assessing the performance of the Cell Painting assay across different imaging systems},
journal = {Cytometry Part A},
year = {2023},
volume = {103},
number = {11},
pages = {915--926},
doi = {10.1002/cyto.a.24786}
}
EUVIMED